Intraoperative Radiation Therapy Market by Products and Services (Products, Systems/Accelerators, Applicators and After loaders, Treatment Planning Systems, Accessories, and Services), Technology (Electron IORT, and Intraoperative Brachytherapy), Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head and Neck Cancer, Colorectal Cancer, Endometrial and Cervical Cancer, Lung Cancer, and Others): Global Market Size Estimates and Forecast (2022-2030)

BMIRE00027051 | Pages: 100 | Medical Device | Oct 2022 | Type: Global | Status: Published

The market crossed the US$ 50.0 million mark in 2022 and is expected to hit US$ 70.0 million by 2030, recording a CAGR of 6.5% during the forecast period.

Rising global prevalence of cancer

The intraoperative radiation therapy procedure is related with various advantages such as targeted radiation, high precision and radiation control, limited treatment time, and minimal radiation exposure of normal tissue.This is mostly true for breast cancer, as this mode offers women a choice of lumpectomy (breast-sparing treatment). The increasing prevalence of breast cancer is, therefore, driving the market growth during the forecast period. The growing prevalence of cancer increases the adoption of IORT procedures. Some key statistics in this regard have been mentioned below:

  • According to in 2020, 276,480 new cases of invasive breast cancer and 48,530 new cases of non-invasive breast cancer were reported in the US.
  • According to the International Agency for Research on Cancer in 2018, around 17.0 million new cases of cancer were reported worldwide; this figure is expected to reach 27.5 million by 2040
  • According to the American Cancer Society, in 2018, around 1.8 million new cases of cancer were diagnosed in the US.

Within the report, the market is segmented into product and services, technology, application, and geography. On the basis of the product and services, the market is segmented into products, systems/accelerators, applicators and after loaders, treatment planning systems, accessories, and services. On the basis of the technology, the market is segmented into Electron IORT, and Intraoperative Brachytherapy.    Further, by application, the market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and others.  Geographically, the market is segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

COVID-19 impact on intraoperative radiation therapy market

The growth in the rate of the lethality of COVID-19 has brought up a global concern for the safety of the global population enforcing the lockout situation. The surge in the demand for the recovery of the patients who are exposed to the virus would need respiratory equipment for better treatment. There is a surge in the usage of these devices globally and hence the manufacturers are taking advantage and hence gaining maximum shares. However, the surgical procedures are now brought to a halt which will lead to the downfall of the other medical devices and supplies. This has also led to a decrease in the growth of Intraoperative Radiation Therapy in the current situation. Furthermore, the use of equipment that can be used to prevent exposure to COVID-19 is anticipated to increase in the near future. The rise in government interference towards the safety of the global population would help the use of personal protective equipment in the commenced period.

The products segment showcases the high growth of the intraoperative radiation therapy market.

Based on products and services, products can be attributed to accounting highest market share during the analysis period owing to their growing availability, development of technologically advanced mobile systems/accelerators, treatment planning, and growing applications of IORT products in cancer treatment.

Recent strategic developments in the intraoperative radiation therapy market

The intraoperative radiation therapy market has undergone several significant developments, and a few of these have been mentioned below:

  • In April 2021, Varian Medical Systems, Inc. entered into an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to fight global cancer burden. This will help the company increase its access to care across regional and underserviced areas in Australia and Asia.
  • In October 2020, IntraOp Medical, Inc. and the University of Verona in Italy announced the enrollment of their first patient in the PancFORT Trial. This has helped the company to advance the science and clinical evidence supporting the role of IORT in treating cancer.

The intraoperative radiation therapy market is driven by several players by implementing strategic activities such as Roche Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd.,  bioMérieux SA, LSI Medience Corporation, DiaSorin S.p.A., and Bio-Rad Laboratories, Inc. are among the prominent players operating in the market.

Target audience for the report:

  • Intraoperative radiation therapy providers
  • Cancer-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities
  • Venture capitalists, private equity firms, and start-up companies
  • End users of Intraoperative radiation therapy
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Product and Services:
    • Products
    • Systems/Accelerators
    • Applicators and After loaders
    • Treatment Planning Systems
    • Accessories
    • Services

  • Technology:
    • Electron IORT
    • Intraoperative Brachytherapy


  • Application:
    • Breast Cancer
    • Brain Tumor
    • Gastrointestinal Cancer
    • Head and Neck Cancer
    • Colorectal Cancer
    • Endometrial and Cervical Cancer
    • Lung Cancer
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
  •  ZEISS Group
  •  iCAD, Inc.
  •  Eckert & Ziegler
  •  Elekta
  •  GMV Innovating Solutions
  •  Sensus Healthcare, Inc.
  •  IntraOp Medical, In
  •  Isoray, Inc
  •  Becton, Dickinson and Company
  •  Sordina IORT Technologies

The List of Companies
- ZEISS Group
- iCAD, Inc.
- Eckert & Ziegler
- Elekta
- GMV Innovating Solutions
- Sensus Healthcare, Inc.
- IntraOp Medical, In
- Isoray, Inc
- Becton, Dickinson and Company
- Sordina IORT Technologies

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Purchase Options
Single User License
Site License
Enterprise License